Gambaran Klinis Pasien Epidural Hematoma Di Rsud Dr. H. Abdul Moeloek Provinsi Lampung

Ansar, Joan Willy; Anggorotomo, Wirawan; Utami, Deviani; Virdaus, Nur Alam

doi:10.33024/jikk.v8i3.4835

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study, only 24.53% of patients had prostate cancer out of 53 patients with prostate disease. This finding follows the research conducted by Siswandi et al at RS Dr. H. Abdul Moeloek who found more benign prostate enlargement (96.3%) than prostate cancer (3.7%) ( 8 ).…”

Section: Discussionsupporting

confidence: 91%

Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer

Daryanto,

Trianto,

Seputra

et al. 2024

Med Arch

View full text Add to dashboard Cite

Background: Prostate cancer is the second leading cause of cancer death in men worldwide. There is no national standard for PSA cut-off levels even through the transrectal prostate biopsy procedure causes many serious complications such as bleeding, infection, and sepsis. Therefore, determining cut-off levels for PSA and PSAD is essential to avoid unnecessary biopsies. Objective: This study aims to determine the Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) cut-off points in patients with suspected prostate cancer. Methods: A retrospective study was conducted from January 2018 until March 2021 in Saiful Anwar General Hospital Malang Indonesia. Inclusion criterias were patients with suspected prostate cancer; > 50 years old; underwent PSA, PSAD, and prostate biopsy. Exclusion criterias were patients refuse to participate in the study and incomplete patient medical record data. Medical records from 53 patients who underwent transrectal ultrasonography (TRUS)-guided prostate biopsy were reviewed. Statistical analysis was performed using Mann-Whitney U, Chi-Square, Fisher’s Exact, and Receiver Operator Characteristic (ROC) curves. Results and Discussion: Medical records conducted 53 patients who met inclusion criteria and underwent transrectal ultrasonography (TRUS)-guided prostate biopsy were reviewed. PSA cut off level for prostate biopsy was 19.71 ng/ml with a sensitivity of 69.23% and a specificity of 72.5%. The positive predictive value is 45% and the negative predictive value is 87.87%. PSAD cut off level for prostate biopsy was 0.4113 with a sensitivity of 61.54% and a specificity of 63.16%. The positive predictive value is 36.36% and the negative predictive value is 82.76%. Conclusion: Results from this study, the cut off levels of PSA and PSAD in prostate disease patients is higher than the recommended cut off; prostate cancer is the largest malignancy in men worldwide and has a higher incidence in the older age and high serum PSA levels group.

show abstract

Section: Discussionsupporting

confidence: 91%

Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer

Daryanto,

Trianto,

Seputra

et al. 2024

Med Arch

View full text Add to dashboard Cite

show abstract

“…Head injuries can cause temporary or permanent disturbances in neurological, physical, cognitive and psychosocial functions. The manifestation is usually accompanied by intracranial bleeding due to rupture of blood vessels in the brain, one of which is Epidural bleeding or Epidural Hematoma (Ansar et al, 2021;Rudyanto et al, 2023;Awaloei et al, 2016;Rawis et al, 2016;Astuti et al, 2016;Siahaya et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Application of Artificial Intelligence in Early Detection of Epidural Hematoma

Asy Syifa,

Ainy,

Wirawan

2024

JII

View full text Add to dashboard Cite

Head injury is an emergency condition that is still the leading cause of death. Manifestations of head injury may be accompanied by intracranial hemorrhage, one of which is epidural hemorrhage or epidural hematoma (EDH). This study aims to explore the potential application of artificial intelligence in the early detection of epidural hematoma with the main objective of improving early diagnosis and management of this condition. This paper uses a literature review study method derived from the analysis of various references. The references used have inclusion criteria in the form of full text type, related to the topic of discussion using "Artificial Intelligence", "Deep learning", and "epidural hematome". The result of this study is that EWS finds the presence of EDH in two or more images from a set of CT-Scans, the system will send an email to the medical practitioner with an attachment of images showing EDH for immediate action. In previous tests, the system successfully diagnosed 13 out of 27 patients with EDH, with 85% of the diagnoses having a high level of importance. This shows that the EWS has the potential to improve early detection and management of EDH cases, as well as provide medical practitioners with important information for appropriate action.

show abstract

Gambaran Klinis Pasien Epidural Hematoma Di Rsud Dr. H. Abdul Moeloek Provinsi Lampung

Cited by 2 publications

References 0 publications

Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer

Evaluation of Cutoff Point Prostate Specific Antigen (PSA) and Prostate Specific Antigen Density (PSAD) in Patients with Suspected Prostate Cancer

Application of Artificial Intelligence in Early Detection of Epidural Hematoma

Contact Info

Product

Resources

About